
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Latency-Reversing Agents Induce Differential Responses in Distinct Memory CD4 T Cell Subsets in Individuals on Antiretroviral Therapy
Marion Pardons, Rémi Fromentin, Amélie Pagliuzza, et al.
Cell Reports (2019) Vol. 29, Iss. 9, pp. 2783-2795.e5
Open Access | Times Cited: 58
Marion Pardons, Rémi Fromentin, Amélie Pagliuzza, et al.
Cell Reports (2019) Vol. 29, Iss. 9, pp. 2783-2795.e5
Open Access | Times Cited: 58
Showing 1-25 of 58 citing articles:
The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies
Lillian B. Cohn, Nicolas Chomont, Steven G. Deeks
Cell Host & Microbe (2020) Vol. 27, Iss. 4, pp. 519-530
Open Access | Times Cited: 218
Lillian B. Cohn, Nicolas Chomont, Steven G. Deeks
Cell Host & Microbe (2020) Vol. 27, Iss. 4, pp. 519-530
Open Access | Times Cited: 218
Curing HIV: Seeking to Target and Clear Persistent Infection
David M. Margolis, Nancie M. Archin, Myron S. Cohen, et al.
Cell (2020) Vol. 181, Iss. 1, pp. 189-206
Open Access | Times Cited: 152
David M. Margolis, Nancie M. Archin, Myron S. Cohen, et al.
Cell (2020) Vol. 181, Iss. 1, pp. 189-206
Open Access | Times Cited: 152
The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells
Gabriel Duette, Bonnie Hiener, Hannah Morgan, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 7
Open Access | Times Cited: 70
Gabriel Duette, Bonnie Hiener, Hannah Morgan, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 7
Open Access | Times Cited: 70
Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4+ and CD8+ T cells
Mathieu Dubé, Olivier Tastet, Caroline Dufour, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 9, pp. 1507-1522.e5
Open Access | Times Cited: 46
Mathieu Dubé, Olivier Tastet, Caroline Dufour, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 9, pp. 1507-1522.e5
Open Access | Times Cited: 46
The Current Status of Latency Reversing Agents for HIV-1 Remission
Anthony Rodari, Gilles Darcis, Carine Van Lint
Annual Review of Virology (2021) Vol. 8, Iss. 1, pp. 491-514
Open Access | Times Cited: 99
Anthony Rodari, Gilles Darcis, Carine Van Lint
Annual Review of Virology (2021) Vol. 8, Iss. 1, pp. 491-514
Open Access | Times Cited: 99
Block-And-Lock: New Horizons for a Cure for HIV-1
Inês Moranguinho, Susana T. Valente
Viruses (2020) Vol. 12, Iss. 12, pp. 1443-1443
Open Access | Times Cited: 73
Inês Moranguinho, Susana T. Valente
Viruses (2020) Vol. 12, Iss. 12, pp. 1443-1443
Open Access | Times Cited: 73
The multifaceted nature of HIV latency
Caroline Dufour, Pierre Gantner, Rémi Fromentin, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 7, pp. 3381-3390
Open Access | Times Cited: 72
Caroline Dufour, Pierre Gantner, Rémi Fromentin, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 7, pp. 3381-3390
Open Access | Times Cited: 72
In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia
Basiel Cole, Laurens Lambrechts, Pierre Gantner, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 60
Basiel Cole, Laurens Lambrechts, Pierre Gantner, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 60
Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes
Caroline Dufour, Corentin Richard, Marion Pardons, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34
Caroline Dufour, Corentin Richard, Marion Pardons, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34
Immunological approaches to HIV cure
Adam R. Ward, Talia M. Mota, R. Brad Jones
Seminars in Immunology (2020) Vol. 51, pp. 101412-101412
Open Access | Times Cited: 62
Adam R. Ward, Talia M. Mota, R. Brad Jones
Seminars in Immunology (2020) Vol. 51, pp. 101412-101412
Open Access | Times Cited: 62
The multifaceted nature of HIV latency
Caroline Dufour, Pierre Gantner, Rémi Fromentin, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 11
Open Access | Times Cited: 55
Caroline Dufour, Pierre Gantner, Rémi Fromentin, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 11
Open Access | Times Cited: 55
HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs
Rémi Fromentin, Nicolas Chomont
Seminars in Immunology (2020) Vol. 51, pp. 101438-101438
Open Access | Times Cited: 51
Rémi Fromentin, Nicolas Chomont
Seminars in Immunology (2020) Vol. 51, pp. 101438-101438
Open Access | Times Cited: 51
Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoir
Marion Pardons, Basiel Cole, Laurens Lambrechts, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Marion Pardons, Basiel Cole, Laurens Lambrechts, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Measuring the Success of HIV-1 Cure Strategies
Jordan Thomas, Alessandra Ruggiero, William A. Paxton, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 44
Jordan Thomas, Alessandra Ruggiero, William A. Paxton, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 44
The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro–Cortistatin A
Chuan Li, Luisa Mori, Susana T. Valente
The Journal of Infectious Diseases (2020) Vol. 223, Iss. Supplement_1, pp. S46-S53
Open Access | Times Cited: 42
Chuan Li, Luisa Mori, Susana T. Valente
The Journal of Infectious Diseases (2020) Vol. 223, Iss. Supplement_1, pp. S46-S53
Open Access | Times Cited: 42
Engineering CAR T Cells to Target the HIV Reservoir
Wenli Mu, Mayra A. Carrillo, Scott G. Kitchen
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 40
Wenli Mu, Mayra A. Carrillo, Scott G. Kitchen
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 40
Defective HIV-1 genomes and their potential impact on HIV pathogenesis
Jeffrey Kuniholm, Carolyn Coote, Andrew J. Henderson
Retrovirology (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 26
Jeffrey Kuniholm, Carolyn Coote, Andrew J. Henderson
Retrovirology (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 26
Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency
Ishak D. Irwan, Hal P. Bogerd, Bryan R. Cullen
Nature Microbiology (2022) Vol. 7, Iss. 12, pp. 2101-2113
Open Access | Times Cited: 23
Ishak D. Irwan, Hal P. Bogerd, Bryan R. Cullen
Nature Microbiology (2022) Vol. 7, Iss. 12, pp. 2101-2113
Open Access | Times Cited: 23
Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure
Natasha N. Duggan, Tatjana Dragic, Sumit K. Chanda, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2435-2435
Open Access | Times Cited: 13
Natasha N. Duggan, Tatjana Dragic, Sumit K. Chanda, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2435-2435
Open Access | Times Cited: 13
Identification of the Inducible HIV reservoir in Tonsillar, Intestinal and Cervical Tissue Models of HIV Latency
Ana Gallego-Cortés, Nerea Sánchez-Gaona, Cristina Mancebo-Pérez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Ana Gallego-Cortés, Nerea Sánchez-Gaona, Cristina Mancebo-Pérez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Integration of long-acting antiretroviral therapies and latency-reversing agents for reservoir reduction and viral suppression: a comprehensive review
Saksham Sharma, Udithi Bandaru, C Soni, et al.
InterConf (2025), Iss. 53(232), pp. 258-270
Closed Access
Saksham Sharma, Udithi Bandaru, C Soni, et al.
InterConf (2025), Iss. 53(232), pp. 258-270
Closed Access
A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
Eugène Kroon, Jintanat Ananworanich, Amélie Pagliuzza, et al.
Journal of Virus Eradication (2020) Vol. 6, Iss. 3, pp. 100004-100004
Open Access | Times Cited: 38
Eugène Kroon, Jintanat Ananworanich, Amélie Pagliuzza, et al.
Journal of Virus Eradication (2020) Vol. 6, Iss. 3, pp. 100004-100004
Open Access | Times Cited: 38
NF-κB sub-pathways and HIV cure: A revisit
Lilly Wong, Guochun Jiang
EBioMedicine (2020) Vol. 63, pp. 103159-103159
Open Access | Times Cited: 38
Lilly Wong, Guochun Jiang
EBioMedicine (2020) Vol. 63, pp. 103159-103159
Open Access | Times Cited: 38
Latency Reversal 2.0: Giving the Immune System a Seat at the Table
Vidisha Singh, Amir Dashti, Maud Mavigner, et al.
Current HIV/AIDS Reports (2021) Vol. 18, Iss. 2, pp. 117-127
Open Access | Times Cited: 32
Vidisha Singh, Amir Dashti, Maud Mavigner, et al.
Current HIV/AIDS Reports (2021) Vol. 18, Iss. 2, pp. 117-127
Open Access | Times Cited: 32
The role of latency reversal in HIV cure strategies
Kiho Tanaka, Youry Kim, Michael Roche, et al.
Journal of Medical Primatology (2022) Vol. 51, Iss. 5, pp. 278-283
Open Access | Times Cited: 19
Kiho Tanaka, Youry Kim, Michael Roche, et al.
Journal of Medical Primatology (2022) Vol. 51, Iss. 5, pp. 278-283
Open Access | Times Cited: 19